MicroRNA‐224 is up‐regulated in hepatocellular carcinoma through epigenetic mechanisms
暂无分享,去创建一个
A. Chung | P. Chow | P. Cole | D. Meyers | H. Toh | L. Ooi | Philip A Cole | Han Chong Toh | Yu Wang | Pierce Chow | Alexander Y F Chung | David J Meyers | London L P J Ooi | Caroline G L Lee | Yu Wang | C. G. Lee
[1] A. Jemal,et al. Global Cancer Statistics , 2011 .
[2] Thomas D. Schmittgen,et al. Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.
[3] W. Sung,et al. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. , 2010, Journal of hepatology.
[4] Ruben Abagyan,et al. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. , 2010, Chemistry & biology.
[5] Xiao-fang Yu,et al. Microarray analysis of microRNA expression in hepatocellular carcinoma and non‐tumorous tissues without viral hepatitis , 2007, Journal of gastroenterology and hepatology.
[6] S. Thorgeirsson,et al. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties , 2009, Oncogene.
[7] C. Croce,et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. , 2007, Cancer research.
[8] Laura Pelletier,et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.
[9] S. D. Selcuklu,et al. miR-21 as a key regulator of oncogenic processes. , 2009, Biochemical Society transactions.
[10] A. Johnsson,et al. HAT–HDAC interplay modulates global histone H3K14 acetylation in gene‐coding regions during stress , 2009, EMBO reports.
[11] Xin Li,et al. MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. , 2010, Molecular endocrinology.
[12] Hong-Yang Wang,et al. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance. , 2002, World journal of gastroenterology.
[13] K. Ghoshal,et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.
[14] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[15] Kuo-Bin Li,et al. Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target* , 2008, Journal of Biological Chemistry.
[16] P. Marks,et al. Histone Deacetylase Inhibitors: Overview and Perspectives , 2007, Molecular Cancer Research.
[17] Peng-jun Zhang,et al. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies , 2010, Clinical science.
[18] Yu Wang,et al. Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention? , 2011, Epigenomics.
[19] Zhimin Zhang,et al. MicroRNA‐224 is upregulated in HepG2 cells and involved in cellular migration and invasion , 2010, Journal of gastroenterology and hepatology.
[20] K. Choy,et al. MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling , 2010, Clinical Cancer Research.
[21] C. Lee,et al. MicroRNA and cancer – focus on apoptosis , 2008, Journal of cellular and molecular medicine.
[22] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[23] Peter Schirmacher,et al. MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma , 2007, Hepatology.
[24] Jian-Rong Yang,et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. , 2009, Cancer research.
[25] Yun Cao,et al. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma , 2011, Journal of Translational Medicine.
[26] T. Okanoue,et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.
[27] Masaru Tomita,et al. Core promoter structure and genomic context reflect histone 3 lysine 9 acetylation patterns , 2010, BMC Genomics.
[28] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[29] B. Stewart,et al. World Cancer Report , 2003 .
[30] Qian Wang,et al. Bead‐based microarray analysis of microRNA expression in hepatocellular carcinoma: miR‐338 is downregulated , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.
[31] G. Goldberg,et al. Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration , 2009, Oncogene.
[32] Mihaela Zavolan,et al. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. , 2008, The American journal of pathology.
[33] S. Lowe,et al. miR-221 overexpression contributes to liver tumorigenesis , 2009, Proceedings of the National Academy of Sciences.
[34] P. Boyle,et al. World Cancer Report 2008 , 2009 .
[35] K. Horimoto,et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma , 2009, Hepatology.